Inventor · Stevenage, GB

Volker Germaschewski

27Patents
6h-index
59Co-inventors
68Inventor score

Filing activity: Aug 5, 2003 → Apr 28, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US9567399B1 Antibodies and immunocytokines Chemistry; Metallurgy 62 Active
US9617338B1 Antibodies and immunocytokines Chemistry; Metallurgy 61 Active
US10604576B2 Antibodies and immunocytokines Chemistry; Metallurgy 17 Active
US7612183B2 Humanised anti-mag antibody or functional fragment thereof Chemistry; Metallurgy 15 Expired
US9957323B2 Anti-ICOS antibodies Chemistry; Metallurgy 14 Active
US10667501B2 Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulins Chemistry; Metallurgy 11 Active
US8858943B2 Antigen binding proteins Chemistry; Metallurgy 6 Active
US8227576B2 Antibodies against amyloid-β peptide Chemistry; Metallurgy 4 Active
US7858753B2 Immunoglobulins Chemistry; Metallurgy 4 Active
US8921523B2 Humanized anti-beta-amyloid antibodies Chemistry; Metallurgy 4 Active
US8071731B2 Humanised anti-MAG antibody or functional fragment thereof Chemistry; Metallurgy 2 Active
US10703814B2 Method of treatment with humanized anti-IL-18 antibodies Chemistry; Metallurgy 2 Active
US8133978B2 Humanised anti-interleukin-18 antibody Chemistry; Metallurgy 2 Active
US8637018B2 Humanized anti-IL-18 antibodies Chemistry; Metallurgy 1 Active
US8496932B2 Compounds Chemistry; Metallurgy 1 Active
US11858996B2 Anti-ICOS antibodies Chemistry; Metallurgy 1 Active
US11965026B2 Anti-PD-L1 and IL-2 cytokines Chemistry; Metallurgy 1 Active
US8828384B2 Compounds Chemistry; Metallurgy 0 Active
US10221234B2 Antigen binding proteins Chemistry; Metallurgy 0 Active
US11440960B2 TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo Emerging Cross-Sectional Technologies 0 Active
US11648308B2 Methods, regimens, combinations and antagonists Chemistry; Metallurgy 0 Active
US12209128B2 Anti-PD-L1 antibodies Chemistry; Metallurgy 0 Active
US8974782B2 Treatment of stroke comprising anti-MAG antibodies Emerging Cross-Sectional Technologies 0 Active
US8362208B2 Immunoglobulins Chemistry; Metallurgy 0 Active
US9499617B2 Humanized anti-IL-18 antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.